|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Refludan (Lepirudin). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (12)
Cases resulting in a serious event (11)
Cases resulting in death (4)
Cases resulting in hospitalization (3)
Cases resulting in disability (1)
Cases resulting in other serious reactions (5)
Adverse event in receiving Refludan (Lepirudin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-15
Patient:
Adverse reactions / side effects: Renal Impairment
Adverse event resulted in: death
Suspect drug(s):
Refludan (Lepirudin)
Other drugs received by patient: Argatroban
Adverse event in female receiving Refludan (Lepirudin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-17
Patient: female, weighing 94.6 kg (208.2 pounds)
Adverse reactions / side effects: Disseminated Intravascular Coagulation, Thrombotic Thrombocytopenic Purpura, Deep Vein Thrombosis, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Ortho Evra
Indication: Drug USE FOR Unknown Indication
Retavase
Indication: Drug USE FOR Unknown Indication
Heparin
Indication: Drug USE FOR Unknown Indication
Refludan
Indication: Drug USE FOR Unknown Indication
Adverse event in receiving Refludan (Lepirudin)
Reported by a individual with unspecified qualification from United States on 2007-07-16
Patient:
Adverse reactions / side effects: Medication Error, Circumstance or Information Capable of Leading TO Medication Error
Suspect drug(s):
Refludan (Lepirudin)
Adverse event in male receiving Refludan (Lepirudin)
Reported by a individual with unspecified qualification from France on 2007-06-15
Patient: male
Adverse reactions / side effects: Thrombosis, Blindness
Adverse event resulted in: disablity
Suspect drug(s):
Refludan
End date: 2006-03-01
Argatroban
Indication: Heparin-Induced Thrombocytopenia
Start date: 2006-03-01
Adverse event in 60 year old female receiving Refludan (Lepirudin)
Reported by a physician from Germany on 2007-05-21
Patient: 60 year old female, weighing 74.8 kg (164.6 pounds)
Adverse reactions / side effects: Thrombosis, Heparin-Induced Thrombocytopenia, Drug Interaction
Suspect drug(s):
Arixtra
Dosage: 1.25mg per day
Indication: Heparin-Induced Thrombocytopenia
Start date: 2007-04-09
End date: 2007-04-13
Refludan
Indication: Heparin-Induced Thrombocytopenia
Start date: 2007-04-09
Fraxiparin
Dosage: .3ml per day
Indication: Thrombosis Prophylaxis
Start date: 2007-03-30
End date: 2007-04-08
Other drugs received by patient: Euthyrox; Perenterol; Digimerck; Metoprolol Succinate; Plavix; Paspertin
Adverse event in receiving Refludan (Lepirudin)
Reported by a pharmacist from United States on 2007-05-02
Patient:
Adverse reactions / side effects: Haemorrhage
Suspect drug(s):
Refludan (Lepirudin)
Adverse event in female receiving Refludan (Lepirudin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-30
Patient: female, weighing 90.7 kg (199.6 pounds)
Adverse reactions / side effects: Disseminated Intravascular Coagulation, Thrombotic Thrombocytopenic Purpura, Deep Vein Thrombosis, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Ortho Evra
Indication: Drug USE FOR Unknown Indication
Retavase
Indication: Drug USE FOR Unknown Indication
Heparin
Indication: Drug USE FOR Unknown Indication
Refludan
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Refludan (Lepirudin)
Reported by a physician from Germany on 2007-04-20
Patient: female
Adverse reactions / side effects: Thrombosis, Drug Interaction
Suspect drug(s):
Arixtra
Refludan
Adverse event in 76 year old female receiving Refludan (Lepirudin)
Reported by a consumer/non-health professional from France on 2007-04-05
Patient: 76 year old female
Adverse reactions / side effects: Tetany, Muscle Spasms
Suspect drug(s):
Refludan (Lepirudin)
Other drugs received by patient: Acetylsalicylic Acid SRT; Molsidomine; Isosorbide Mononitrate; Enalapril Maleate; Epogen; Sodium Ferrigluconate; Pancreatin Triple Strength CAP; Oestriol + Oestradiol; Pantoprazole; Calcium Citrate; Alfacalcidol
Adverse event in 64 year old female receiving Refludan (Lepirudin)
Reported by a physician from France on 2007-03-01
Patient: 64 year old female
Adverse reactions / side effects: Oedema Peripheral, Platelet Count Decreased, General Physical Health Deterioration
Suspect drug(s):
Refludan (Lepirudin)
Adverse event in female receiving Refludan (Lepirudin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-15
Patient: female
Adverse reactions / side effects: Disseminated Intravascular Coagulation, Thrombotic Thrombocytopenic Purpura, Deep Vein Thrombosis, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Ortho Evra
Indication: Drug USE FOR Unknown Indication
Retevase
Indication: Drug USE FOR Unknown Indication
Heparin
Indication: Drug USE FOR Unknown Indication
Refludan
Indication: Drug USE FOR Unknown Indication
Adverse event in 73 year old male receiving Refludan (Lepirudin)
Reported by a individual with unspecified qualification from United States on 2007-01-31
Patient: 73 year old male, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Cardiac Tamponade, Heparin-Induced Thrombocytopenia, Pericardial Effusion
Adverse event resulted in: hospitalization
Suspect drug(s):
Heparin Sodium
Dosage: dose unit:unknown
Indication: Acute Coronary Syndrome
Angiomax
Indication: Acute Coronary Syndrome
Start date: 2005-09-20
End date: 2005-09-20
Angiomax
Start date: 2005-09-20
End date: 2005-09-27
Aspirin
Indication: Drug USE FOR Unknown Indication
Refludan
Dosage: dose unit:unknown
Indication: Drug USE FOR Unknown Indication
Coumadin
Dosage: dose unit:unknown
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Amiodarone HCL
|
